SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- AbbVie ASEAN has been ranked #15 in the inaugural Fortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work®, ...

Shares of Eli Lilly & Co. rose 3.38% to $1,062.19 Monday, on what proved to be an all-around grim trading session for the ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...

Keli Walbert brings decades of commercial leadership experience and a proven track record of successful product launches in rare diseaseSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...

David Dietze, chief investment strategist at Dietze Wealth Management, joins BNN Bloomberg to discuss the outlook for the ...

Motif ? one of the clinical trial technology market's fastest growing companies ? continues contributing to major innovations in how clinical trial patient data are collected, with Chief Scientific ...

An intriguing quant signal combined with shifting sentiment in the derivatives market opens the possibility toward a bullish ...

Singapore, December 15: AbbVie ASEAN has been ranked #15 in the inaugural Fortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work, highlighting workplaces ...

Discover three high-quality US dividend stocks that combine stable payouts, global growth, and long-term compounding ...

JPMorgan Equity Premium Income ETF delivers consistent monthly income with a 7-8% yield, though it lags the broader market's ...

The model portfolios combine mutual funds and ETFs and are geared toward mass affluent and high-net-worth investors.